Rationale for WHO's new position calling for prompt reporting and public disclosure of interventional clinical trial results
about
Developing Global Norms for Sharing Data and Results during Public Health EmergenciesRandomised trials in context: practical problems and social aspects of evidence-based medicine and policyBest practices for sharing information through data platforms: establishing the principlesKnowledge sharing during public health emergencies: from global call to effective implementationNon-Publication Is Common among Phase 1, Single-Center, Not Prospectively Registered, or Early Terminated Clinical Drug TrialsA metadata schema for data objects in clinical researchOpen data 5 years on: a case series of 12 freedom of information requests for regulatory data to the European Medicines AgencyDeriving meaningful insights from clinical trial and postmarketing safety data: Perspectives from IndiaPublication and reporting of clinical trial results: cross sectional analysis across academic medical centers.Evidence-based medicine meets person-centred care: a collaborative perspective on the relationship.How to get all trials reported: audit, better data, and individual accountability.Translating research findings to clinical nursing practice.Improving data transparency in clinical trials using blockchain smart contracts.Getting our house in order: an audit of the registration and publication of clinical trials supported by the National Institute for Health Research Oxford Biomedical Research Centre and the Musculoskeletal Biomedical Research Unit.Publication and non-publication of drug trial results: a 10-year cohort of trials in Norwegian general practice.Pipelle for Pregnancy (PIP): study protocols for three randomised controlled trials.Cross-sectional study of Pfizer-sponsored clinical trials: assessment of time to publication and publication history.Cross-sectional assessment of patient attitudes towards participation in clinical trials: does making results publicly available matter?The evolution in registration of clinical trials: a chronicle of the historical calls and current initiatives promoting transparency.Factors impacting time to acceptance and publication for peer-reviewed publications.Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies.Appraisal of a redundant report on lanthanum carbonate.Determinants of selective reporting: A taxonomy based on content analysis of a random selection of the literature.Promoting innovation and access to quality, safe, efficacious, and affordable medicines for children: A China approach on the 69th World Health Assembly.Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines.Compliance with requirement to report results on the EU Clinical Trials Register: cohort study and web resourceCross-sectional analysis of UK research studies in 2015: results from a scoping project with the UK Health Research AuthorityA randomized pragmatic care trial on endovascular acute stroke interventions (EASI): criticisms, responses, and ethics of integrating research and clinical care
P2860
Q23331292-30FCEA1D-75D1-4393-847D-204A8ED1BFEDQ26784106-7E57FD5C-9254-4F57-AAC0-8A68B2E6B9F8Q27469125-EC793FAB-EEF0-4DF1-9F40-8DE0ED3C9555Q27469127-D7354404-6987-4CB0-87A6-72DDA5938109Q28555016-CAB1F955-3635-47E2-B59E-26CACD4BA313Q28593411-9AE6EE23-91B9-4EA5-86E8-C52C0DF4B515Q28600964-10D91DAF-7214-415F-A2FA-8B10D99F088EQ29994550-21151120-2A5B-4150-B1BA-CD44C0F90C2BQ30360244-2AC8F17F-1087-4362-B3FF-FC0A19ACCB43Q30379048-324D4742-445A-431B-9FA4-D26A491AAE6EQ30932208-5E264872-7460-4987-B7F7-11A70BD8E933Q33578497-47A11344-4669-44D5-8E52-2B6B5A2EE4B4Q36327615-66657FB7-0878-45C2-9D75-AB600A4BE4BCQ36670574-8976984B-5479-4B5D-B53E-BB00A31642D4Q36819100-9CA26D3D-5D59-4253-8211-182F5E2E808EQ36842532-EE947780-965A-491D-81B1-1981D4AC0DD4Q37133927-E62258D6-EED5-4D3B-A699-2A7377E7150EQ37516789-9BEDC4C9-EC16-49FF-9CBD-AB0AE48CD15BQ38560675-56A1336E-AA43-4EAE-9740-0C47FF4C67D3Q39098841-A817573A-908E-48D1-9291-F41096F62AA0Q46177929-3E20344E-93C7-41BB-9C17-43BEC24C1503Q47626616-A3BF1BC7-8571-44D9-824E-8492D988C41EQ48105455-828E0C05-469F-4AE6-B388-DCF081BA9857Q48658057-F4425E43-7F3E-4A09-A804-6280E05A49F5Q52662743-15B64719-AA98-4301-8989-88322D33AA1FQ57262049-51FE7CAC-93F0-4CFE-B3BF-F6BD2685CF50Q58605458-DD9EDA73-A379-4DAB-89B9-38610F4A84EEQ58657021-32EF8A25-F641-49B7-9A46-8BE4157A16A3
P2860
Rationale for WHO's new position calling for prompt reporting and public disclosure of interventional clinical trial results
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Rationale for WHO's new positi ...... ntional clinical trial results
@ast
Rationale for WHO's new positi ...... ntional clinical trial results
@en
Rationale for WHO's new positi ...... ntional clinical trial results
@en-gb
Rationale for WHO's new positi ...... ntional clinical trial results
@nl
type
label
Rationale for WHO's new positi ...... ntional clinical trial results
@ast
Rationale for WHO's new positi ...... ntional clinical trial results
@en
Rationale for WHO's new positi ...... ntional clinical trial results
@en-gb
Rationale for WHO's new positi ...... ntional clinical trial results
@nl
prefLabel
Rationale for WHO's new positi ...... ntional clinical trial results
@ast
Rationale for WHO's new positi ...... ntional clinical trial results
@en
Rationale for WHO's new positi ...... ntional clinical trial results
@en-gb
Rationale for WHO's new positi ...... ntional clinical trial results
@nl
P2093
P2860
P3181
P1433
P1476
Rationale for WHO's new positi ...... ntional clinical trial results
@en
P2093
Ghassan Karam
Kirsten S Vannice
Marie-Paule Kieny
P2860
P304
P3181
P356
10.1371/JOURNAL.PMED.1001819
P407
P577
2015-04-01T00:00:00Z